• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CORCYM CANADA CORP. PERCEVAL SUTURELESS AORTIC HEART VALVE; TISSUE HEART VALVE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CORCYM CANADA CORP. PERCEVAL SUTURELESS AORTIC HEART VALVE; TISSUE HEART VALVE Back to Search Results
Model Number PVS23
Device Problem Leak/Splash (1354)
Patient Problem Aortic Valve Insufficiency/ Regurgitation (4450)
Event Date 01/25/2021
Event Type  malfunction  
Manufacturer Narrative
The manufacturing and material records for the perceval heart valve, model #icv1209 , s/n # (b)(4), as they pertain to the reported event, were retrieved and reviewed by the manufacturer's quality engineering, including a review of the steady flow test.The results confirmed that this valve satisfied all material, visual, and performance standards required for a (model #icv1209) perceval heart valve at the time of manufacture and release.The review of the steady flow test confirmed that no anomalies were observed in the valve during the open/close cycle.Copies of the echocardiography performed were received and reviewed by an external consultant.The tte dated (b)(6) 2021 is of poor quality and has low image count.It shows normal lv function (ef 55-60%) and normal rv function.Valvular evaluation shows trivial ar and trivial mr.No pericardial effusion is seen.The tee dated (b)(6) 2021 shows that the anterior aortic prosthetic leaflet is thickened and with reduced mobility, suggesting leaflet thrombosis.There is mild central ar and the prosthetic valve seems to be in good position.The manufacturer has requested additional information on this event, but none has been provided to date.Since the device remains implanted, no further investigation is possible at this time.Based on the investigation performed and information available, it is not possible to provide a final judgment on the event and the device.However, from the document review performed, no manufacturing deficiencies were identified.Considering that a moderate central leak was present since the time of implant, the postoperative finding of central aortic insufficiency can be considered as a stable condition present since the time of implant, rather than to a late inception of a dysfunction of the device.Based on the manufacturer¿s clinical experience, possible root causes for events of intra-operative central leak could be related to procedural factors like device missing or device mispositioning.However, this can not be ultimately confirmed based on the available information and given that no inspection on the device was possible.Furthermore, although the echo imaging review suggests a possible thrombosis, this information was not received from the site.Ultimately, since the patient's conditions were stable and no device-reintervention occurred, there is no evidence to suspect a serious injury for the patient as a result of the reported event.Should any further information be received, a follow-up report will be provided.Device remains implanted.
 
Event Description
On (b)(6) 2021, a perceval size m was implanted as part of an aortic valve replacement procedure.A concomitant cabg (lita-lad svg-4pd) was performed.The cross-clamp duration was 208 min.Transesophageal echocardiography after declamping showed a mild-level central leak.On (b)(6) 2021, the transesophageal echocardiography was performed again, and it was confirmed that central leak of mild-trace remained.The patient's condition was stable and the patient's discharge was planned after rehabilitation.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PERCEVAL SUTURELESS AORTIC HEART VALVE
Type of Device
TISSUE HEART VALVE
Manufacturer (Section D)
CORCYM CANADA CORP.
5005 north fraser way
burnaby, bc V5J 5 M1
CA  V5J 5M1
Manufacturer (Section G)
CORCYM CANADA CORP.
5005 north fraser way
burnaby, bc V5J 5 M1
CA   V5J 5M1
Manufacturer Contact
francesca crovato
5005 north fraser way
burnaby, bc V5J 5-M1
CA   V5J 5M1
MDR Report Key14690936
MDR Text Key301365383
Report Number3004478276-2022-00156
Device Sequence Number1
Product Code LWR
UDI-Device Identifier00896208000429
UDI-Public(01)00896208000429(240)ICV1209(17)230709
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
P150011
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 06/14/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/14/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date07/09/2023
Device Model NumberPVS23
Device Catalogue NumberCV1209
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Date Manufacturer Received05/18/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured07/09/2020
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age77 YR
Patient SexMale
-
-